An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules
Authors
Keywords
-
Journal
PLoS One
Volume 13, Issue 10, Pages e0205491
Publisher
Public Library of Science (PLoS)
Online
2018-10-16
DOI
10.1371/journal.pone.0205491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fludarabine and neurotoxicity in engineered T-cell therapy
- (2018) Kate L. Lowe et al. GENE THERAPY
- Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use
- (2017) Fiona Sewell et al. mAbs
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Drug Development of Therapeutic Monoclonal Antibodies
- (2016) Diane R. Mould et al. BIODRUGS
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy
- (2016) Marine C C Raman et al. Scientific Reports
- Transcriptome of human foetal heart compared with cardiomyocytes from pluripotent stem cells
- (2015) C. W. van den Berg et al. DEVELOPMENT
- Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
- (2015) Max S Topp et al. LANCET ONCOLOGY
- ImmTACs for targeted cancer therapy: Why, what, how, and which
- (2015) Joanne Oates et al. MOLECULAR IMMUNOLOGY
- Progressive multifocal leukoencephalopathy: current treatment options and future perspectives
- (2015) Dejan Pavlovic et al. Therapeutic Advances in Neurological Disorders
- ImmTAC-redirected tumour cell killing induces and potentiates antigen cross-presentation by dendritic cells
- (2014) Giovanna Bossi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells
- (2014) Giovanna Bossi et al. OncoImmunology
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Overcoming Current Limitations in Humanized Mouse Research
- (2013) Michael A. Brehm et al. JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity of mAbs in non-human primates during nonclinical safety assessment
- (2013) Peter J.K. van Meer et al. mAbs
- Meeting report: The future of preclinical mouse models in melanoma treatment is now
- (2013) Glenn Merlino et al. Pigment Cell & Melanoma Research
- Identification of a Titin-Derived HLA-A1-Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3-Directed T Cells
- (2013) B. J. Cameron et al. Science Translational Medicine
- Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
- (2012) Emmet McCormack et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Monoclonal TCR-redirected tumor cell killing
- (2012) Nathaniel Liddy et al. NATURE MEDICINE
- Understanding the Melanocyte Distribution in Human Epidermis: An Agent-Based Computational Model Approach
- (2012) Josef Thingnes et al. PLoS One
- Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγnull H2-Ab1 tm1Gru Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease
- (2011) L. Covassin et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Development of a human whole blood assay for prediction of cytokine release similar to anti-CD28 superagonists using multiplex cytokine and hierarchical cluster analysis
- (2011) Mindi R. Walker et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Defining the critical hurdles in cancer immunotherapy
- (2011) Bernard A Fox et al. Journal of Translational Medicine
- Building a Tiered Approach to In Vitro Predictive Toxicity Screening: A Focus on Assays with In Vivo Relevance
- (2010) James McKim Jr. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
- (2010) Frank R. Brennan et al. mAbs
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-7 Enhances Thymic Human T Cell Development in "Human Immune System" Rag2-/-IL-2R c-/- Mice without Affecting Peripheral T Cell Homeostasis
- (2009) A. U. van Lent et al. JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation